文献速递主动脉疾病

机构与术者手术量对破裂腹主动脉瘤修复结局影响的系统评价与荟萃分析

Editor's Choice - Systematic Review and Meta-Analysis of the Impact of Institutional and Surgeon Procedure Volume on Outcomes After Ruptured Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-08-09

该系统评价与荟萃分析纳入13项研究共120 116例破裂腹主动脉瘤患者,评估机构或术者手术量与结局的相关性。低容量中心患者围手术期死亡率显著高于高容量中心(OR 1.39;95%CI 1.22-1.59),开放修复的获益比EVAR更明显,而术者手术量差异无统计学意义。

要点

  • 低容量中心rAAA修复围手术期死亡率显著高于高容量中心(OR 1.39;95%CI 1.22-1.59)。
  • 高容量中心获益在开放修复中更明显(校正后OR 1.68;95%CI 1.21-2.33),EVAR校正后不显著。
  • 低与高容量术者间围手术期死亡率差异无统计学意义(EVAR OR 1.06;开放OR 1.18)。

核心结论

  • 高机构手术量可能降低破裂腹主动脉瘤修复后的围手术期死亡率。
  • 该围手术期生存优势在开放手术中比EVAR更明显。
  • 术者个人手术量未发现对结局有显著影响。

研究设计与样本

  • 系统评价与荟萃分析,遵循PRISMA指南,方案注册于PROSPERO(CRD42020213121)。
  • 检索MEDLINE、Embase、CINAHL和CENTRAL,纳入比较高低容量机构或术者结局的预后研究。
  • 共纳入13项研究,合计120 116例患者。
  • 围手术期死亡率合并估计采用Mantel-Haenszel法计算OR及95%CI,校正结局估计采用通用逆方差法分析。

主要发现

  • 低容量中心患者围手术期死亡率显著高于高容量中心(OR 1.39;95%CI 1.22-1.59)。
  • 亚组分析显示高容量中心在EVAR(OR 1.61;95%CI 1.11-2.35)和开放修复(OR 1.50;95%CI 1.25-1.81)中均有死亡率优势。
  • 校正分析显示高容量中心对开放修复有获益(OR 1.68;95%CI 1.21-2.33),对EVAR无显著获益(OR 1.42;95%CI 0.84-2.41)。
  • 低与高容量术者间围手术期死亡率差异在EVAR(OR 1.06;95%CI 0.59-1.89)和开放修复(OR 1.18;95%CI 0.87-1.63)中均无统计学意义。

关键数值与推荐

  • 低容量中心 vs 高容量中心围手术期死亡率:OR 1.39;95%CI 1.22-1.59。
  • EVAR亚组低容量 vs 高容量中心:OR 1.61;95%CI 1.11-2.35。
  • 开放修复亚组低容量 vs 高容量中心:OR 1.50;95%CI 1.25-1.81。
  • 校正后开放修复低容量 vs 高容量中心:OR 1.68;95%CI 1.21-2.33;校正后EVAR:OR 1.42;95%CI 0.84-2.41。

临床怎么用

  • rAAA修复应优先考虑在高容量中心进行,以降低围手术期死亡风险。
  • 高容量中心获益在开放修复中证据更充分,EVAR的机构容量获益需进一步验证。
  • 术者个人手术量不应作为rAAA修复结局的唯一决策依据。

局限性

  • 纳入研究为预后研究,可能存在未测量混杂。
  • EVAR校正分析置信区间跨1,机构容量对EVAR的独立效应不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether there is a correlation between institutional or surgeon case volume and outcomes in patients with ruptured abdominal aortic aneurysm (rAAA). DATA SOURCES: The Healthcare Database Advanced Search interface developed by the National Institute of Health and Care Excellence was used to search MEDLINE, Embase, CINAHL, and CENTRAL. REVIEW METHODS: The systematic review complied with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines with the protocol registered in PROSPERO (CRD42020213121). Prognostic studies were considered comparing outcomes of patients with rAAA undergoing repair in high and low volume institutions or by high and low volume surgeons. Pooled estimates for peri-operative mortality were calculated using the odds ratio (OR) and 95% confidence intervals (CI), applying the Mantel-Haenszel method. Analysis of adjusted outcome estimates was performed with the generic inverse variance method. RESULTS: Thirteen studies reporting a total of 120 116 patients were included. Patients treated in low volume centres had a statistically significantly higher peri-operative mortality than those treated in high volume centres (OR 1.39; 95% CI 1.22 - 1.59). Subgroup analysis showed a mortality difference in favour of high volume centres for both endovascular aneurysm repair (EVAR; OR 1.61, 95% CI 1.11 - 2.35) and open repair (OR 1.50, 95% CI 1.25 - 1.81). Adjusted analysis showed a benefit of treatment in high volume centres for open repair (OR 1.68, 95% CI 1.21 - 2.33) but not for EVAR (OR 1.42, 95% CI 0.84 - 2.41). Differences in peri-operative mortality between low and high volume surgeons were not statistically significant for either EVAR (OR 1.06, 95% CI 0.59 - 1.89) or open surgical repair (OR 1.18, 95% CI 0.87 - 1.63). CONCLUSION: A high institutional volume may result in a reduction of peri-operative mortality following surgery for rAAA. This peri-operative survival advantage is more pronounced for open surgery than EVAR. Individual surgeon caseload was not found to have a significant impact on outcomes.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kontopodis N, Galanakis N, Akoumianakis E, et al. Editor's Choice - Systematic Review and Meta-Analysis of the Impact of Institutional and Surgeon Procedure Volume on Outcomes After Ruptured Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2021. PMID: 34384687. doi:10.1016/j.ejvs.2021.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。